Document is current

Population Pharmacokinetics of ABT-806, an Investigational Anti-Epidermal Growth Factor Receptor (EGFR) Monoclonal Antibody, in Advanced Solid Tumor Types Likely to Either Over-Express Wild-Type EGFR or Express Variant III Mutant EGFR

Crossref DOI link: https://doi.org/10.1007/s40262-015-0258-2

Published Online: 2015-03-12

Published Print: 2015-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy